CartiHeal
Privately-held medical device company that develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints.
Launch date
Employees
Market cap
-
Enterprise valuation
$60—90m (Dealroom.co estimates Jul 2020.)
Company register number 514279645
Kfar Saba Center District (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$5.0m | Series D | ||
$10.0m | Late VC | ||
$5.0m | Late VC | ||
$3.0m | Late VC | ||
$15.0m | Late VC | ||
$18.3m | Late VC | ||
* | $2.5m | Late VC | |
$15.0m | Late VC | ||
N/A | Acquisition | ||
* | $330m | Acquisition | |
| Total Funding | $74.8m | ||
Related Content
Recent News about CartiHeal
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.